MassMutual Private Wealth & Trust’s Tvardi Therapeutics TVRD Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3	Closed	-$530	–	2027
2023 Q1	$530	Hold	3	–	–	﹤0.01%	1670
2022 Q4	$1K	Sell	3 -2	-40%	-$760	﹤0.01%	1594
2022 Q3	$2K	Buy	5 +3	+150%	+$1.09K	﹤0.01%	1315
2022 Q2	$1K	Buy	+2	New	+$702	﹤0.01%	1458
2022 Q1	–	Sell	-1	Closed	-$1K	–	1661
2021 Q4	$1K	Buy	+1	New	+$502	﹤0.01%	1342
2018 Q4	–	Sell	-7	Closed	-$5.99K	–	1048
2018 Q3	$5.99K	Hold	7	–	–	﹤0.01%	687
2018 Q2	$4.79K	Hold	7	–	–	﹤0.01%	734
2018 Q1	$3.1K	Hold	7	–	–	﹤0.01%	771
2017 Q4	$3.06K	Hold	7	–	–	﹤0.01%	715
2017 Q3	$3.42K	Buy	7 +3	+75%	+$1.5K	﹤0.01%	879
2017 Q2	$2.31K	Buy	+4	New	+$2.54K	﹤0.01%	893

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MassMutual Private Wealth & Trust's TVRD Position: Q2 2023 in Review

MassMutual Private Wealth & Trust sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 3 shares — an estimated $530 sold.

MassMutual Private Wealth & Trust first reported a position in TVRD in Q2 2017 and held it in 11 quarters. The position peaked at $5.99K in Q3 2018. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

MassMutual Private Wealth & Trust reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 3 Tvardi Therapeutics shares in Q2 2023, an estimated $530.
MassMutual Private Wealth & Trust first reported a position in Tvardi Therapeutics in Q2 2017 and held it in 11 quarters.
MassMutual Private Wealth & Trust's Tvardi Therapeutics position peaked at $5.99K in Q3 2018.
137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2023, filed 2 Aug 2023.